Intech Investment Management LLC acquired a new position in shares of U.S. Physical Therapy, Inc. (NYSE:USPH – Free Report) in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund acquired 4,207 shares of the company’s stock, valued at approximately $356,000.
Several other institutional investors also recently bought and sold shares of the business. First Horizon Advisors Inc. lifted its position in shares of U.S. Physical Therapy by 25.1% during the third quarter. First Horizon Advisors Inc. now owns 1,486 shares of the company’s stock worth $126,000 after purchasing an additional 298 shares in the last quarter. Howe & Rusling Inc. lifted its position in shares of U.S. Physical Therapy by 22.5% during the third quarter. Howe & Rusling Inc. now owns 4,864 shares of the company’s stock worth $412,000 after purchasing an additional 893 shares in the last quarter. Quest Partners LLC lifted its position in shares of U.S. Physical Therapy by 2,368.2% during the third quarter. Quest Partners LLC now owns 8,614 shares of the company’s stock worth $729,000 after purchasing an additional 8,265 shares in the last quarter. Sugar Maple Asset Management LLC acquired a new position in shares of U.S. Physical Therapy during the third quarter worth $212,000. Finally, KBC Group NV lifted its position in shares of U.S. Physical Therapy by 68.6% during the third quarter. KBC Group NV now owns 774 shares of the company’s stock worth $66,000 after purchasing an additional 315 shares in the last quarter.
U.S. Physical Therapy Stock Performance
Shares of USPH opened at $98.99 on Wednesday. The firm has a 50-day moving average price of $86.93 and a 200 day moving average price of $90.29. The firm has a market capitalization of $1.49 billion, a PE ratio of 105.49, a P/E/G ratio of 4.49 and a beta of 1.46. The company has a quick ratio of 1.78, a current ratio of 1.78 and a debt-to-equity ratio of 0.27. U.S. Physical Therapy, Inc. has a 52-week low of $76.18 and a 52-week high of $113.63.
U.S. Physical Therapy Dividend Announcement
Analysts Set New Price Targets
Several analysts recently issued reports on the stock. JPMorgan Chase & Co. upped their price target on shares of U.S. Physical Therapy from $117.00 to $120.00 and gave the company an “overweight” rating in a report on Tuesday. Bank of America reaffirmed a “neutral” rating and issued a $90.00 price target (down from $114.00) on shares of U.S. Physical Therapy in a report on Monday, October 7th. Barrington Research reaffirmed an “outperform” rating and issued a $108.00 price target on shares of U.S. Physical Therapy in a report on Thursday, November 21st. Finally, StockNews.com raised shares of U.S. Physical Therapy from a “sell” rating to a “hold” rating in a report on Wednesday, August 21st.
Check Out Our Latest Report on U.S. Physical Therapy
Insider Activity at U.S. Physical Therapy
In other U.S. Physical Therapy news, COO Graham D. Reeve sold 1,724 shares of the company’s stock in a transaction dated Friday, November 8th. The shares were sold at an average price of $96.29, for a total transaction of $166,003.96. Following the completion of the sale, the chief operating officer now directly owns 7,106 shares of the company’s stock, valued at approximately $684,236.74. This represents a 19.52 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Bernard A. Harris, Jr. sold 2,000 shares of the company’s stock in a transaction dated Tuesday, November 12th. The shares were sold at an average price of $92.95, for a total transaction of $185,900.00. Following the sale, the director now directly owns 16,726 shares of the company’s stock, valued at $1,554,681.70. This represents a 10.68 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 6,896 shares of company stock worth $656,940 in the last 90 days. Corporate insiders own 1.70% of the company’s stock.
U.S. Physical Therapy Profile
U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.
Featured Stories
- Five stocks we like better than U.S. Physical Therapy
- Find and Profitably Trade Stocks at 52-Week Lows
- Beyond NVIDIA: Top 5 Semiconductor Stocks to Watch for 2025
- What is the Australian Securities Exchange (ASX)
- Netflix Is On Track To Hit $1,000 By Christmas
- How to Invest in Insurance Companies: A GuideĀ
- UMAC Stock Climbs Amid Trump Jr. Appointment and Meme Stock Hype
Want to see what other hedge funds are holding USPH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for U.S. Physical Therapy, Inc. (NYSE:USPH – Free Report).
Receive News & Ratings for U.S. Physical Therapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy and related companies with MarketBeat.com's FREE daily email newsletter.